A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate

DMF Medical

Status: Completed

Conditions: CO2 Removal; End Tidal CO2

Treatments: Device: memsorb

Study type: Interventional

Funder types: Industry

Identifiers

NCT02195245

DMF-CLIN-14-01

Details and patient eligibility

About

CO2 removal is a mandatory part of modern anesthesia systems. Current chemical absorbers pose problems as the chemical granulate reacts not only with the CO2 but also the anesthetic drugs, producing organ toxic substances. The proposed CO2 absorber provides a solution to the problem of organ-toxin production in anesthetic circuits.

Full description

CO2 removal is a mandatory part of modern anesthesia systems. Current chemical absorbers pose problems as the chemical granulate reacts not only with the CO2 but also the anesthetic drugs, producing organ toxic substances. The proposed CO2 absorber provides a solution to the problem of organ-toxin production in anesthetic circuits.

This new absorber can be easily integrated into any anesthesia circuit, and can effectively remove CO2 without reacting with anesthetic drugs, thus eliminating organ-toxic by-products.

It uses advanced membrane technology to separate gas flows within the circuit, separating the expensive anesthetic vapors from the CO2 (the main by-product of metabolism). Anesthetic vapors thus remain in the closed loop circuit, while CO2 is separated and exhausted to the atmosphere, rather than being absorbed through a chemical reaction.

Enrollment: 20 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• American Society of Anesthesiology Physical Status Class I, II, III (low-medium risk patient)
• English-speaking patients
• Scheduled for elective surgery
• Length of anesthesia ≥ 60 minutes

Exclusion criteria

• Pregnant
• American Society of Anesthesiology Physical Status Class IV (high risk patient)
• Patients schedule for emergency surgery
• Known respiratory disease, including COPD and severe asthma
• Have elevated pressure in your brain (intra cranial pressure, ICP)

Trial design

20 participants in 2 patient groups

Control

No Intervention group

Description:

Control - Observational (non interventional) data is collected from current state of the art absorber devices.

memsorb

Experimental group

Description:

New CO2 filter - data is collected using the new CO2 absorber.

Treatment:

Device: memsorb